LSE:HLN (Haleon plc)
About HLN
Haleon (NYSE: HLN) is a leading global consumer health company with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health, Therapeutic Skin Health, and Wellness. Built on trusted science, innovation, and deep human understanding, Haleon's U.S. brands include Abreva, Advil, Benefiber, Centrum, Emergen-C, Excedrin, Flonase, Gas-X, Nexium, Nicorette, Parodontax, Polident, Preparation H, Pronamel, Sensodyne, Robitussin, Theraflu, TUMS, Voltaren, and more.
Haleon plc (LSE: HLN) Latest News
Investing Articles
If I’d put £1,000 in Haleon shares 1 year ago, here’s what I’d have now!
Investing Articles
Are Haleon shares a long-term bargain?
Investing Articles
If I’d invested £1,000 in the Haleon shares spin-off, here’s how much I’d have now
Investing Articles
Up 32%, are Haleon shares the best FTSE 100 buy in June?
Investing Articles
Should investors buy Haleon shares today?
Investing Articles
UK stocks to buy amid a cost-of-living crisis!
Growth Shares
These 3 top banks think the Haleon share price will rally. What should I do?
Investing Articles
If I’d invested £100 in Haleon shares at launch, here’s how much I’d have now!
Investing Articles
Was I dumb to sell my GSK shares?
Investing Articles
2 dirt-cheap shares I’ve bought to hold for 30 years!
Investing Articles
The Haleon share price is back near where it started. Should I buy the stock now?